ATE410427T1 - Neues kristallines tricyclisches triazolobenzazepinderivat - Google Patents

Neues kristallines tricyclisches triazolobenzazepinderivat

Info

Publication number: ATE410427T1
Authority: AT; Austria
Prior art keywords: new crystalline; derivative; tricyclic triazolobenzazepine; triazolobenzazepine derivative; crystalline tricyclic
Prior art date: 2001-12-26

Application number

AT02790870T

Other languages

English (en)

Inventor

S Kitahara

Hanae Furukawa

Toshihiro Yamaguchi

S Miyamoto

Yumiko Okada

Original Assignee

Meiji Seika Kaisha

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-26

Filing date

2002-12-25

Publication date

2008-10-15

2002-12-25 Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha

2008-10-15 Application granted granted Critical

2008-10-15 Publication of ATE410427T1 publication Critical patent/ATE410427T1/de

Links

QDEVEJYEXBFIJD-UHFFFAOYSA-N triazolo[4,5-i][1]benzazepine Chemical class C1=CC2=CC=CC=NC2=C2C1=NN=N2 QDEVEJYEXBFIJD-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Rheumatology (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT02790870T 2001-12-26 2002-12-25 Neues kristallines tricyclisches triazolobenzazepinderivat ATE410427T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2001393016		2001-12-26

Publications (1)

Publication Number	Publication Date
ATE410427T1 true ATE410427T1 (de)	2008-10-15

Family

ID=19188739

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT02790871T ATE469902T1 (de)	2001-12-26	2002-12-25	Amorphe substanz eines tricyclischen triazolobenzazepinderivats
AT02790870T ATE410427T1 (de)	2001-12-26	2002-12-25	Neues kristallines tricyclisches triazolobenzazepinderivat

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT02790871T ATE469902T1 (de)	2001-12-26	2002-12-25	Amorphe substanz eines tricyclischen triazolobenzazepinderivats

Country Status (11)

Country	Link
US (2)	US7229985B2 (de)
EP (2)	EP1469000B1 (de)
JP (2)	JPWO2003055885A1 (de)
KR (1)	KR100848724B1 (de)
CN (1)	CN1275968C (de)
AT (2)	ATE469902T1 (de)
AU (2)	AU2002367109A1 (de)
CA (1)	CA2471651C (de)
DE (2)	DE60229298D1 (de)
ES (2)	ES2312650T3 (de)
WO (2)	WO2003055886A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004113343A1 (ja) *	2003-06-19	2004-12-29	Meiji Seika Kaisha, Ltd.	三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質
US20070167402A1 (en) *	2003-06-20	2007-07-19	Meiji Seika Kaisha, Ltd.	Product of coprecipitation of sparingly soluble substance and water-soluble polymer and process for producing the same
JPWO2007100079A1 (ja) *	2006-03-02	2009-07-23	明治製菓株式会社	三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤
TW200843903A (en) *	2007-05-03	2008-11-16	Univ Nat Central	Abrasives with function of sliding grinding and its manufacturing method
RU2469724C2 (ru) *	2007-12-18	2012-12-20	Мейдзи Сейка Фарма Ко., Лтд.	Профилактическое или терапевтическое вещество при воспалительных болезнях кишечника
WO2009123169A1 (ja) *	2008-04-02	2009-10-08	アステラス製薬株式会社	アミド誘導体含有医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR19990087585A (ko)	1996-03-08	1999-12-27	돈 리사 로얄	신경학적 활성제로서의 아졸로벤즈아제핀 유도체
US6574603B1 (en) *	1997-09-26	2003-06-03	Gilbarco Inc.	In-vehicle ordering
DK1026167T3 (da) *	1997-09-29	2003-05-26	Meiji Seika Kaisha	Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler

2002
- 2002-12-25 DE DE60229298T patent/DE60229298D1/de not_active Expired - Lifetime
- 2002-12-25 US US10/500,071 patent/US7229985B2/en not_active Expired - Fee Related
- 2002-12-25 AT AT02790871T patent/ATE469902T1/de not_active IP Right Cessation
- 2002-12-25 JP JP2003556415A patent/JPWO2003055885A1/ja active Pending
- 2002-12-25 CA CA2471651A patent/CA2471651C/en not_active Expired - Fee Related
- 2002-12-25 WO PCT/JP2002/013558 patent/WO2003055886A1/ja not_active Ceased
- 2002-12-25 DE DE60236623T patent/DE60236623D1/de not_active Expired - Lifetime
- 2002-12-25 KR KR1020047010203A patent/KR100848724B1/ko not_active Expired - Fee Related
- 2002-12-25 JP JP2003556416A patent/JP4376628B2/ja not_active Expired - Fee Related
- 2002-12-25 ES ES02790870T patent/ES2312650T3/es not_active Expired - Lifetime
- 2002-12-25 AT AT02790870T patent/ATE410427T1/de not_active IP Right Cessation
- 2002-12-25 EP EP02790870A patent/EP1469000B1/de not_active Expired - Lifetime
- 2002-12-25 CN CNB028275470A patent/CN1275968C/zh not_active Expired - Fee Related
- 2002-12-25 EP EP02790871A patent/EP1466914B1/de not_active Expired - Lifetime
- 2002-12-25 ES ES02790871T patent/ES2346858T3/es not_active Expired - Lifetime
- 2002-12-25 AU AU2002367109A patent/AU2002367109A1/en not_active Abandoned
- 2002-12-25 WO PCT/JP2002/013557 patent/WO2003055885A1/ja not_active Ceased
- 2002-12-25 US US10/500,157 patent/US7002009B2/en not_active Expired - Fee Related
- 2002-12-25 AU AU2002367110A patent/AU2002367110A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20050130955A1 (en)	2005-06-16
DE60236623D1 (de)	2010-07-15
ATE469902T1 (de)	2010-06-15
CA2471651C (en)	2010-01-26
DE60229298D1 (de)	2008-11-20
EP1466914A1 (de)	2004-10-13
EP1469000A4 (de)	2005-12-07
ES2346858T3 (es)	2010-10-21
CA2471651A1 (en)	2003-07-10
KR100848724B1 (ko)	2008-07-25
EP1469000B1 (de)	2008-10-08
WO2003055885A1 (en)	2003-07-10
EP1466914A4 (de)	2005-12-07
CN1275968C (zh)	2006-09-20
CN1617872A (zh)	2005-05-18
US20050020579A1 (en)	2005-01-27
EP1466914B1 (de)	2010-06-02
EP1469000A1 (de)	2004-10-20
KR20040072682A (ko)	2004-08-18
WO2003055886A1 (en)	2003-07-10
AU2002367110A1 (en)	2003-07-15
JPWO2003055886A1 (ja)	2005-09-02
US7229985B2 (en)	2007-06-12
JPWO2003055885A1 (ja)	2005-05-12
ES2312650T3 (es)	2009-03-01
US7002009B2 (en)	2006-02-21
JP4376628B2 (ja)	2009-12-02
AU2002367109A1 (en)	2003-07-15

Legal Events

Date	Code	Title	Description
2009-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
MA26937A1 (fr)	2004-12-20	Nouvelle composition pharmaceutique.
DE60214428D1 (de)	2006-10-12	1, 4-dihydro-1, 4-diphenylpyridin-derivate
IT1308627B1 (it)	2002-01-09	Composizioni fluoroelastomeriche.
IT1308628B1 (it)	2002-01-09	Composizioni fluoroelastomeriche.
DE69922267D1 (de)	2004-12-30	Bewegliches zusammensetzspiel
ATE404528T1 (de)	2008-08-15	7,9 substituierte tetracyclinverbindungen
IL168784A (en)	2010-12-30	Fused 1,3-dihydroimidazole ring compounds and pharmaceutical compositions comprising the same
ATE295081T1 (de)	2005-05-15	Hilfsstoff-zusammensetzung
DE60010601D1 (de)	2004-06-17	Vernetzbare Fluorelastomerzusammensetzungen
MXPA03006991A (es)	2003-11-18	Derivados de piperidina como antagonistas de neurocinina 1.
DZ3155A1 (fr)	2000-11-02	Nouvelle composition pharmaceutique.
ID28483A (id)	2001-05-31	2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
DE60031148D1 (de)	2006-11-16	Uv-vernetzbare polymerzusammensetzung
DE60210598D1 (de)	2006-05-24	3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
DE50107988D1 (de)	2005-12-15	Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
DK1458413T3 (da)	2009-11-23	Farmaceutiske sammensætninger på b asis af azetidin-derivater
NL1016364A1 (nl)	2001-04-24	Vuurvaste thermoplastische harssamenstelling.
DE60025958D1 (de)	2006-04-20	14,15-beta-methylen substituierte androgene
DE60020341D1 (de)	2005-06-30	Kerzenzusammensetzung
ATE410427T1 (de)	2008-10-15	Neues kristallines tricyclisches triazolobenzazepinderivat
NO20042980L (no)	2004-07-14	3,4-dihydro-1H-isokinolin-2-yl-derivater
DE50208676D1 (de)	2006-12-28	Builder-Zusammensetzung
ITTO20020744A1 (it)	2003-02-25	Composizione.
MXPA03005965A (es)	2003-09-05	Composicion farmaceutica que contiene citalopram.
ZA200110500B (en)	2002-04-03	Pharmaceutical composition.